### **Overview** Black Rose Industries Ltd. (BSE-listed) is an integrated Indian specialty and performance chemicals company with operations spanning **chemical manufacturing**, **chemical distribution**, and a minor presence in **renewable energy and textiles**. The company has evolved from a distributor of specialty chemicals since 1990 into a technically advanced manufacturer through strategic vertical integration. It operates a world-scale, single-site manufacturing facility in **Jhagadia, Gujarat**, and maintains a 100% subsidiary in Japan (B.R. Chemicals Co. Ltd.) for market access and export facilitation. --- ### **Core Business Segments** #### **1. Chemical Manufacturing** Black Rose’s manufacturing division leverages in-house R&D and collaborations with global partners (notably Mitsui Chemicals, Japan) to produce acrylamide-based derivatives and specialty chemicals. **Key Products & Capacities:** - **Acrylamide Liquid**: 32,000 MTPA (20,000 MTPA for merchant sales, balance for captive use). - **Acrylamide Solid (Powder)**: 3,600 MTPA – *the only global manufacturer outside China*, giving Black Rose a unique competitive and geopolitical advantage. - **Polyacrylamide Liquid (BRILBIND® CE01/CE03)**: 40,000 MTPA – used primarily as a binder in the **Morbi ceramic tile industry** (accounts for ~80% of India’s ceramic output). - **N-Methylol Acrylamide (NMA)**: 2,000 MTPA – two grades (NMA 48% and NMA LF); the **only Indian manufacturer** and a key import substitute. **Strategic Focus & Milestones:** - **Polyacrylamide Solid Technology**: In final stages of development; pilot trials completed, commercial production expected next fiscal year with a planned **10,000 MTPA plant**. This product targets water treatment and industrial applications beyond ceramics. - **NMA Business**: Robust growth in FY24–25; holds **dominant domestic market share** and has expanded exports due to a **proprietary stabilized version** of NMA that overcomes typical shelf-life limitations. Focus now is on international market penetration. - **R&D Hub**: Inaugurated a **new central R&D facility in Navi Mumbai (May 2025)**, enhancing innovation in new chemistries, process optimization, and green chemistry. - **Capacity Expansion**: The acrylamide solid plant is scaling with strong domestic and export demand. Management is evaluating further capacity increases. --- #### **2. Chemical Distribution** Represents **~70% of total revenue**, growing 29% in value and 10% in volume during FY24–25. The company imports and distributes high-margin specialty chemicals from global suppliers (primarily in **Japan, Germany, and Thailand**) such as resorcinol, ethanolamines, isophthalic acid, and meta cresol. **Key Strengths:** - **Deep Supplier Relationships**: Direct partnerships with key principals (e.g., Mitsui, Sumitomo, LANXESS, GC Glycol), bypassing traditional intermediaries, ensuring reliable supply and fair pricing. - **Resilient Stock-and-Sale Model**: Enables service continuity during global supply disruptions. - **Market Expansion**: Strong domestic demand supported by diversified end-use industries (agrochemicals, paints, pharmaceuticals, oil & gas). Exports to the **US oil and gas sector** remain steady despite tariff uncertainties. **Strategic Direction:** - Strengthening product portfolio and customer base. - Capitalizing on global de-risking trends (“China +1” and “Europe +1”) as multinational customers seek diversified supply chains. - Focused on new product launches and geographic reach expansion. --- #### **3. Strategic Projects and Collaborations** - **Specialty Amines Joint Venture with Koei Chemical (Japan)**: - Feasibility studies underway for manufacturing specialty amines in India. - Black Rose to provide infrastructure and operational expertise; Koei to provide technology. - Demonstrates the company’s ability to convert distribution relationships into manufacturing opportunities. - **Toll Manufacturing Projects**: In advanced discussions with US and European partners to produce acrylamide-based chemistries. - **Land Acquisition**: Procured 20 acres for future projects, ensuring readiness for expansion without land acquisition delays. --- ### **Market Position & Competitive Edge** - **Global Niche Leadership**: - **Sole non-Chinese producer** of acrylamide solid. - **Leading domestic supplier** of N-methylol acrylamide (NMA). - **Export Focus**: Strengthening export footprint with EU REACH and Turkey REACH registrations. Target markets include **Europe, North & South America, and Southeast Asia**. - **Technology & R&D**: In-house process development, stable NMA technology, and proprietary binder formulations (e.g., BRILBIND CE03, a higher-performance ceramic binder). - **Operational Efficiency**: Plant design allows low incremental CapEx for expansion and benefits from vertical integration. --- ### **Recent Performance (as of Nov 2025)** | **Segment** | **Key Developments** | |-----------------------------|------------------------| | **Acrylamide Solid** | Pricing stabilized due to rising Chinese import costs. Gaining export traction and expanding domestic customer base. Capacity utilization increasing. | | **Polyacrylamide Liquid** | Market faced weak demand in Morbi due to high gas prices, transport strikes, and unorganized competition. In response, launched **BRILBIND CE03**, which is regaining market share and showing >50% sales growth in initial months. Exploring **bulk packaging** to improve competitiveness. | | **NMA** | Exclusive supplier to key domestic customers. Expanded customer base during the quarter despite seasonal demand weakness. Growing export pipeline. | | **Distribution** | Resilient despite trade volatility. Stable supplier support, diversified portfolio, and strong inventory management driving volume growth. | --- ### **Financial and Operational Highlights** - Steady profitability driven by: - Improved realization in acrylamide solid. - Higher exports with favorable freight and pricing. - Stable raw material (acrylonitrile) costs. - Distribution business remains stable with strong supplier backing. - Manufacturing division showing strong growth in acrylamide and NMA, partially offsetting weaker demand in PAM liquids. --- ### **Challenges** - **Chinese Competition**: Aggressive dumping in acrylamide solid segment pressures domestic pricing. - **Morbi Market Constraints**: Unorganized producers and economic volatility affect PAM liquid demand. - **Seasonal & Geopolitical Factors**: Gas prices, export demand fluctuations, Red Sea shipping delays. - **Product Validation Timelines**: NMA and new binder grades require extended customer trials. ---